These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 48532)

  • 1. The relationship of thyroxine turnover to other parameters of peripheral thyroid function in Graves' disease.
    Clifton-Bligh P; Burke G
    J Lab Clin Med; 1975 Jun; 85(6):922-33. PubMed ID: 48532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laboratory tests for evaluating thyroid therapy.
    Kabadi UM
    Am Fam Physician; 1982 Sep; 26(3):183-8. PubMed ID: 6180620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypothyroidism as a late sequela in patient with Graves' disease treated with antithyroid agents.
    Wood LC; Ingbar SH
    J Clin Invest; 1979 Nov; 64(5):1429-36. PubMed ID: 91625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
    He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of combination therapy with propylthiouracil and cholestyramine in the treatment of Graves' hyperthyroidism.
    Tsai WC; Pei D; Wang TF; Wu DA; Li JC; Wei CL; Lee CH; Chen SP; Kuo SW
    Clin Endocrinol (Oxf); 2005 May; 62(5):521-4. PubMed ID: 15853819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous measurement of thyroxine and triiodothyronine peripheral turnover kinetics in man.
    Nicoloff JT; Low JC; Dussault JH; Fisher DA
    J Clin Invest; 1972 Mar; 51(3):473-83. PubMed ID: 4110897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroid dysfunction in chronic renal failure. A study of the pituitary-thyroid axis and peripheral turnover kinetics of thyroxine and triiodothyronine.
    Lim VS; Fang VS; Katz AI; Refetoff S
    J Clin Invest; 1977 Sep; 60(3):522-34. PubMed ID: 408377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interpretation of serum tri-iodothyronine levels measured by the sterling technic.
    Wahner HW; Gorman CA
    N Engl J Med; 1971 Feb; 284(5):225-30. PubMed ID: 4992676
    [No Abstract]   [Full Text] [Related]  

  • 9. Assessment of thyroid function with hormone assays.
    Liewendahl K
    Ann Chir Gynaecol; 1983; 72(3):84-9. PubMed ID: 6414358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Current aspects of thyroid function diagnostics. Serum T 3 level and TRH stimulation test with radioimmunologic TSH determination].
    Pickardt CR; Horn K; Scriba PC
    Internist (Berl); 1972 Apr; 13(4):133-40. PubMed ID: 4113173
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical experience with sensitive thyrotropin measurements: diagnostic and therapeutic implications.
    Bayer MF; Kriss JP; McDougall IR
    J Nucl Med; 1985 Nov; 26(11):1248-56. PubMed ID: 3840528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triiodothyronine and thyroxine interrelationships in health and disease.
    Walfish PG
    Can Med Assoc J; 1976 Aug; 115(4):338-42. PubMed ID: 953904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum thyrotropin response to thyrotropin-releasing hormone and free thyroid hormone indices in patients with familiar thyroxine-binding globulin deficiency.
    Konno N
    Endocrinol Jpn; 1976 Aug; 23(4):313-7. PubMed ID: 828576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triiodothyronine, thyroxine, and iodine in purified thyroglobulin from patients with Graves' disease.
    Izumi M; Larsen PR
    J Clin Invest; 1977 Jun; 59(6):1105-12. PubMed ID: 577211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T3 toxicosis in adolescence: presentation as recurrent hyperthyroidism.
    AvRuskin TW; Tang S; Shenkman L; Hollander CS
    Pediatrics; 1973 Nov; 52(5):649-52. PubMed ID: 4126724
    [No Abstract]   [Full Text] [Related]  

  • 16. Thyroxine, triiodothyronine, and thyrotropin in serum during long-term diphenylhydantoin therapy.
    Liewendahl K; Majuri H
    Scand J Clin Lab Invest; 1976 Mar; 36(2):141-4. PubMed ID: 179126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid function during pregnancy in women with past Graves' disease.
    Luton D; Le Gac I; Noel M; Guibourdenche J; Polak M
    BJOG; 2005 Nov; 112(11):1565-7. PubMed ID: 16225580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inappropriate suppression of thyrotropin during medical treatment of Graves disease in childhood.
    Sills IN; Horlick MN; Rapaport R
    J Pediatr; 1992 Aug; 121(2):206-9. PubMed ID: 1640284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum thyrotropin response to thyrotropin-releasing hormone and free thyroid hormone indices in patients with familial thyroxine-binding globulin deficiency.
    Konno N
    Endocrinol Jpn; 1977 Aug; 23(4):313-7. PubMed ID: 72658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serum thyroxine and triiodothyronine levels after a single dose and after 2-month-long thiamazole treatment of Graves' disease with reference to drug's pharmacokinetics].
    Syrenicz A
    Ann Acad Med Stetin; 1990; 36():133-52. PubMed ID: 2099104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.